Triple-negative breast cancer (TNBC) is a subtype of breast cancer characterized by minimal expression of estrogen and progesterone receptor and an absence of human epidermal growth factor receptor-2 (HER2) overexpression. The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.